Philips (NYSE:PHG) announced today that it teamed up with Icometrix to deploy an AI-driven brain scan solution.

Royal Philips, a global leader in health technology, and computer-aided diagnostics company icometrix (Leuven, Belgium) have ...

Royal Philips (PHG) and icometrix have teamed up to deploy an AI-driven, end-to-end solution for acquiring, reading, and reporting the results ...

Philips' next-generation BlueSeal 1.5T magnetic resonance imaging (MRI) system will be unveiled at the 2024 Radiological ...

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and computer-aided diagnostics company icometrix (Le ...

Long-term use of many common cardiovascular drugs was tied to fewer dementia diagnoses but anti-platelet use of any duration ...

Steve Salloway at Butler Hospital in Providence, Rhode Island, has consulted for icometrix, the company that developed icobrain aria. He is enthusiastic about the software’s potential, noting that it ...

granted icometrix clearance for icobrain aria, the first and only AI software approved for detecting, measuring and grading amyloid-related imaging abnormalities (ARIA), a potentially harmful side ...

The hospital system has contracted with icometrix, an AI medical imaging company, to use its cutting-edge 'icobrain' AI software. icobrain software analyzes brain MRI scans with greater precision ...

The agency also authorized icometrix's AI-driven MRI software to detect and grade amyloid-related imaging abnormalities (ARIA) in Alzheimer's patients treated with amyloid-targeting therapies.

The FDA authorizes icobrain aria as the first and only AI solution to detect, diagnose, and monitor ARIA for individuals with Alzheimer's disease On November 7 th 2024, the U.S. Food and Drug ...